Search Results - rinku+dutta

1 Results Sort By:
Mithramycin A in Combination with Cancer Immunotherapy
Competitive Advantages Reformulated combination therapeutic allows for shorter clinical pathway Targets cancer stem cells and their ability to escape the immune system More effective at inhibiting tumor growth than either treatment alone Summary Our researchers have formulated a method to target cancer stem cells (CSCs) using Mithramycin...
Published: 9/25/2023   |   Inventor(s): Subhra Mohapatra, Shyam Mohapatra, Rinku Dutta, Quarni Waise
Keywords(s): Cancer Treatment, Medical Therapeutics Cell Therapy
Category(s): Technology Classifications > Cancer, Technology Classifications > Medical > Pharmaceuticals, Technology Classifications > Medical